BLISS GVS PHARMA
Back to Cashflow Statement
|
BLISS GVS PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹139 Cr | ₹106 Cr | ₹103 Cr | ₹34 Cr | ₹135 Cr |
What is the latest Cash Flow from Operating Activities ratio of BLISS GVS PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹139 Cr |
| Mar2025 | ₹106 Cr |
| Mar2024 | ₹103 Cr |
| Mar2023 | ₹34 Cr |
| Mar2022 | ₹135 Cr |
How is Cash Flow from Operating Activities of BLISS GVS PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹139 Cr | 30.97 | |
| Mar2025 | ₹106 Cr | 3.01 | |
| Mar2024 | ₹103 Cr | 199.64 | |
| Mar2023 | ₹34 Cr | -74.67 | |
| Mar2022 | ₹135 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹4,877.9 Cr | -4.6% | 44.8% | 235.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,803.0 Cr | 2.8% | 1.8% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,219.0 Cr | -0.2% | -0.1% | 3.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,417.0 Cr | 1.4% | -1.5% | 39.9% | Stock Analytics | |
| CIPLA | ₹116,116.0 Cr | 6% | 1.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,874.0 Cr | 4.8% | -0.3% | -0.9% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | -4.6% |
44.8% |
235.8% |
| SENSEX | -0.2% |
2.1% |
-5.6% |
You may also like the below Video Courses